Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3632352rdf:typepubmed:Citationlld:pubmed
pubmed-article:3632352lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:3632352lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:3632352lifeskim:mentionsumls-concept:C1882727lld:lifeskim
pubmed-article:3632352lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:3632352lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:3632352lifeskim:mentionsumls-concept:C0005052lld:lifeskim
pubmed-article:3632352lifeskim:mentionsumls-concept:C1549542lld:lifeskim
pubmed-article:3632352pubmed:issue4lld:pubmed
pubmed-article:3632352pubmed:dateCreated1987-10-21lld:pubmed
pubmed-article:3632352pubmed:abstractTextThe metabolism of 1 mM benzo(a)pyrene was studied in isolated perfused lung and liver of 5,6-benzoflavone-pretreated rats. Benzo(a)pyrene metabolism by the liver was more rapid than by the lung, but total metabolite formation in the lung at the end of a 120-min perfusion period was comparable to that in the liver. Lung perfusate was characterized by high concentrations of free metabolites, with diols outweighing phenols; in liver perfusate free metabolite concentrations were low, and large quantities of metabolites were found as conjugates in the bile at the end of perfusion. The tissue concentrations of free diols and phenols including the precursors of the main DNA-binding secondary metabolites were higher in the lung than in the liver. These findings explain the similar level of covalent binding in perfused lung and liver previously described (Klaus et al. 1982).lld:pubmed
pubmed-article:3632352pubmed:languageenglld:pubmed
pubmed-article:3632352pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3632352pubmed:citationSubsetIMlld:pubmed
pubmed-article:3632352pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3632352pubmed:statusMEDLINElld:pubmed
pubmed-article:3632352pubmed:monthJunlld:pubmed
pubmed-article:3632352pubmed:issn0340-5761lld:pubmed
pubmed-article:3632352pubmed:authorpubmed-author:KahnTTlld:pubmed
pubmed-article:3632352pubmed:authorpubmed-author:KahlG FGFlld:pubmed
pubmed-article:3632352pubmed:authorpubmed-author:DowdJ CJClld:pubmed
pubmed-article:3632352pubmed:authorpubmed-author:MollièreMMlld:pubmed
pubmed-article:3632352pubmed:issnTypePrintlld:pubmed
pubmed-article:3632352pubmed:volume60lld:pubmed
pubmed-article:3632352pubmed:ownerNLMlld:pubmed
pubmed-article:3632352pubmed:authorsCompleteYlld:pubmed
pubmed-article:3632352pubmed:pagination270-7lld:pubmed
pubmed-article:3632352pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3632352pubmed:meshHeadingpubmed-meshheading:3632352-...lld:pubmed
pubmed-article:3632352pubmed:meshHeadingpubmed-meshheading:3632352-...lld:pubmed
pubmed-article:3632352pubmed:meshHeadingpubmed-meshheading:3632352-...lld:pubmed
pubmed-article:3632352pubmed:meshHeadingpubmed-meshheading:3632352-...lld:pubmed
pubmed-article:3632352pubmed:meshHeadingpubmed-meshheading:3632352-...lld:pubmed
pubmed-article:3632352pubmed:meshHeadingpubmed-meshheading:3632352-...lld:pubmed
pubmed-article:3632352pubmed:meshHeadingpubmed-meshheading:3632352-...lld:pubmed
pubmed-article:3632352pubmed:meshHeadingpubmed-meshheading:3632352-...lld:pubmed
pubmed-article:3632352pubmed:meshHeadingpubmed-meshheading:3632352-...lld:pubmed
pubmed-article:3632352pubmed:meshHeadingpubmed-meshheading:3632352-...lld:pubmed
pubmed-article:3632352pubmed:year1987lld:pubmed
pubmed-article:3632352pubmed:articleTitleComparison of benzo(a)pyrene metabolism in isolated perfused rat lung and liver.lld:pubmed
pubmed-article:3632352pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3632352pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3632352pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3632352pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3632352lld:pubmed